Literature DB >> 16424384

Telomerase regulation of myofibroblast differentiation.

Tianju Liu1, Biao Hu, Myoung Ja Chung, Matt Ullenbruch, Hong Jin, Sem H Phan.   

Abstract

Telomerase activity, which has wide expression in cancerous cells, is induced in lung proliferating fibroblasts. It is preferentially expressed in fibroblasts versus myofibroblasts. It is unknown whether regulation of telomerase expression is related to the process of fibroblast differentiation into myofibroblasts. The objective of this study was to clarify such a potential link between telomerase expression and myofibroblast differentiation. Telomerase inhibitor, 3'-azido-2',3'-dideoxythymidine, or antisense oligonucleotide to the telomerase RNA component was used to inhibit the induced fibroblast telomerase activity. The results showed that inhibition of induced telomerase increased alpha-smooth muscle actin expression, an indicator of myofibroblast differentiation. In contrast, induction of telomerase by basic fibroblast growth factor inhibited alpha-smooth muscle actin expression. These findings suggest that the loss of telomerase activity is closely associated with myofibroblast differentiation and possibly functions as a trigger for myofibroblast differentiation. Conversely, expression of telomerase suppresses myofibroblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424384      PMCID: PMC2644224          DOI: 10.1165/rcmb.2005-0252OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  40 in total

1.  Basic FGF-induced activation of telomerase in rheumatoid synoviocytes.

Authors:  H Tsumuki; T Hasunuma; T Kobata; T Kato; A Uchida; K Nishioka
Journal:  Rheumatol Int       Date:  2000       Impact factor: 2.631

Review 2.  Studies of the molecular mechanisms in the regulation of telomerase activity.

Authors:  J P Liu
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

Review 3.  Telomerase activity, cell proliferation, and cancer.

Authors:  C W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Activation of telomerase by silica in rat lung.

Authors:  J K Kim; Y Lim; K A Kim; M S Seo; J D Kim; K H Lee; C Y Park
Journal:  Toxicol Lett       Date:  2000-01-05       Impact factor: 4.372

5.  Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.

Authors:  D E Gomez; A M Tejera; O A Olivero
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

6.  Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.

Authors:  Y Tamura; M Tao; N Miyano-Kurosaki; K Takai; H Takaku
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-04

7.  Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.

Authors:  Germana Zaccagnini; Carlo Gaetano; Linda Della Pietra; Simona Nanni; Annalisa Grasselli; Antonella Mangoni; Roberta Benvenuto; Manuela Fabrizi; Silvia Truffa; Antonia Germani; Fabiola Moretti; Alfredo Pontecorvi; Ada Sacchi; Silvia Bacchetti; Maurizio C Capogrossi; Antonella Farsetti
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

8.  Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.

Authors:  S M Melana; J F Holland; B G Pogo
Journal:  Clin Cancer Res       Date:  1998-03       Impact factor: 12.531

9.  Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

Authors:  K A Kolquist; L W Ellisen; C M Counter; M Meyerson; L K Tan; R A Weinberg; D A Haber; W L Gerald
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

10.  Inhibition of human telomerase by 2'-O-methyl-RNA.

Authors:  A E Pitts; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more
  22 in total

Review 1.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 2.  Muscle fatigue: MK2 signaling and myofibroblast differentiation.

Authors:  James S Hagood; Mitchell A Olman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11       Impact factor: 6.914

3.  Biology of fibroblasts and myofibroblasts.

Authors:  Sem H Phan
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 4.  Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts.

Authors:  Troy Stevens; Sem Phan; Maria G Frid; Diego Alvarez; Erica Herzog; Kurt R Stenmark
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

5.  Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation.

Authors:  Biao Hu; Zhe Wu; Tianju Liu; Matthew R Ullenbruch; Hong Jin; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-20       Impact factor: 6.914

6.  Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.

Authors:  Tianju Liu; Francina Gonzalez De Los Santos; Yuyue Zhao; Zhe Wu; Andrew E Rinke; Kevin K Kim; Sem H Phan
Journal:  J Biol Chem       Date:  2019-04-18       Impact factor: 5.157

7.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

8.  Telomerase and telomere length in pulmonary fibrosis.

Authors:  Tianju Liu; Matthew Ullenbruch; Yoon Young Choi; Hongfeng Yu; Lin Ding; Antoni Xaubet; Javier Pereda; Carol A Feghali-Bostwick; Peter B Bitterman; Craig A Henke; Annie Pardo; Moises Selman; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

9.  Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.

Authors:  Tianju Liu; Myoung Ja Chung; Matthew Ullenbruch; Hongfeng Yu; Hong Jin; Biao Hu; Yoon Young Choi; Fuyuki Ishikawa; Sem H Phan
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Nkx2.5/Csx represses myofibroblast differentiation.

Authors:  Biao Hu; Yue Ming Wu; Zhe Wu; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.